The series of patients described here, reinforces previous findings and further delineates the range of clinical observations caused by mutations in VARS2, which should be investigated in early‐onset mitochondrial encephalomyopathies or encephalocardiomyopathies. This evidence concerns the gene VARS2 and mitochondrial encephalomyopathy.